It is a pharma private limited company based in Girwa, Rajasthan, India, established in 2017.
2017 | Girwa, Rajasthan, India | ActiveChinar Therapeutics Private Limited, a active private limited company, was established on 28 June 2017 in Girwa, Rajasthan, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74999RJ2017PTC058432. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 32 professional, Its leadership includes Naresh Sharma (Director), Grijesh Agal (Additional Director). Past directors included Swati Sharma. It holds ₹6.60 M open charges and ₹5.81 M settled loans. Its latest AGM occurred on 20 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. B-176, South Extension Scheme Balicha, Girwa, Rajasthan, 313001.
U74999RJ2017PTC058432
058432
28 June 2017
₹0.10 M
₹0.10 M
Roc Jaipur
Unlisted
Active
Explore comprehensive insights into Chinar Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Naresh Sharma | Director | 28 Jun 2017 | Current |
| Grijesh Agal | Additional Director | 22 Apr 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 Apr 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Chinar Therapeutics Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.9% increase. The company also saw a slight improvement in profitability, with a 5.27% increase in profit. The company's net worth Soared by an impressive increase of 35.23%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Chinar Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹6,600,000.00
₹5,805,024.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2024 | Others | ₹1.65 M | Open |
| 31 Mar 2024 | Others | ₹4.95 M | Open |
| 07 Dec 2022 | Yes Bank Limited | ₹5.00 M | Satisfied |
| 21 Oct 2021 | Hdfc Bank Limited | ₹0.81 M | Satisfied |
Explore comprehensive loan charge details -
Chinar Therapeutics has a workforce of 32 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Chinar Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chinar Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Chinar Therapeutics Private Limited last Annual general meeting of members was held on 20 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on Grijesh Agal was appointed as a Additional Director was appointed as a Additional Director on 22 Apr 2025 & has been associated with this company since 8 months 5 days . was documented.
The activity Chinar Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur. was completed.
A charge with Others of Rs. 1.65 M registered on 31 Mar 2024 with Charge ID 100933844 was modified on 27 Dec 2024. was recorded as a recent event.
Progress on A charge with Others of Rs. 4.95 M registered on 31 Mar 2024 with Charge ID 100933831 was modified on 27 Dec 2024. was documented.
A charge registered on 21 Oct 2021 via Charge ID 100496522 with Hdfc Bank Limited was fully satisfied on 06 Nov 2024. was recorded as a recent event.
The CIN of Chinar Therapeutics Private Limited is U74999RJ2017PTC058432.
Chinar Therapeutics Private Limited is headquartered at Plot No. B-176, South Extension Scheme Balicha, Girwa, Rajasthan, 313001.
Chinar Therapeutics Private Limited was incorporated on 28 June 2017.
The current directors of Chinar Therapeutics Private Limited are
The primary industry of Chinar Therapeutics Private Limited is Manufacturing.
Chinar Therapeutics Private Limited is unlisted.
The authorized capital of Chinar Therapeutics Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Chinar Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX